InnovHeart rallies $55m Series C

InnovHeart, a developer of novel transcatheter mitral valve replacement systems for the treatment of mitral valve disease, has raised $55 million in Series C financing.

InnovHeart, a developer of novel transcatheter mitral valve replacement systems for the treatment of mitral valve disease, has raised $55 million in Series C financing. Grand Pharma led the round with participation from Genextra, Panakes Partners and Indaco Venture Partners.

Source: Press Release